WallStreetZenWallStreetZen

NASDAQ: LPCN
Lipocine Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their LPCN stock forecasts and price targets.

Forecast return on equity

Is LPCN forecast to generate an efficient return?
Company
-1.34%
Industry
47.27%
Market
33.63%
LPCN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is LPCN forecast to generate an efficient return on assets?
Company
-1.26%
Industry
13.28%
LPCN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

LPCN earnings per share forecast

What is LPCN's earnings per share in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$1.00
Avg 2 year Forecast
-$0.06

LPCN revenue growth forecast

How is LPCN forecast to perform vs Biotechnology companies and vs the US market?
Company
318.14%
Industry
271.87%
Market
13.37%
LPCN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LPCN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LPCN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
LPCN$7.69N/AN/A
CRIS$6.94$26.00+274.64%Strong Buy
OKYO$1.59$7.00+340.25%Buy
ALGS$0.52N/AN/A
MTNB$0.17N/AN/A

Lipocine Stock Forecast FAQ

What is LPCN's earnings growth forecast for 2024-2025?

(NASDAQ: LPCN) Lipocine's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 20.6%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 35.52%.

Lipocine's earnings in 2024 is -$8,968,231.On average, 1 Wall Street analyst forecast LPCN's earnings for 2024 to be -$5,347,940, with the lowest LPCN earnings forecast at -$5,347,940, and the highest LPCN earnings forecast at -$5,347,940.

In 2025, LPCN is forecast to generate -$320,876 in earnings, with the lowest earnings forecast at -$320,876 and the highest earnings forecast at -$320,876.

If you're new to stock investing, here's how to buy Lipocine stock.

What is LPCN's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: LPCN) forecast ROE is -1.34%, which is considered weak.

What is LPCN's Earnings Per Share (EPS) forecast for 2024-2025?

(NASDAQ: LPCN) Lipocine's current Earnings Per Share (EPS) is -$1.70. On average, analysts forecast that LPCN's EPS will be -$1.00 for 2024, with the lowest EPS forecast at -$1.00, and the highest EPS forecast at -$1.00. In 2025, LPCN's EPS is forecast to hit -$0.06 (min: -$0.06, max: -$0.06).

What is LPCN's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: LPCN) forecast ROA is -1.26%, which is lower than the forecast US Biotechnology industry average of 13.28%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.